Mission BioCapital

Massachusetts

Mission BioCapital is a life science venture capital firm that invests in early-stage companies. The company leadership team has a long history together, investing in and launching dozens of early-stage life science companies. They are located in regions with a rich concentration of research, discovery, and venture capital investment, and they areknown by leaders of portfolio companies for the expertise and deep support they provide.

Founded:2009

Firm Location:Massachusetts • San Francisco, California • Durham, North Carolina • Cambridge, Massachusetts • San Francisco Bay Area

Investor Firms That Co-Invest with Mission BioCapital

Canaan Partners Polaris Partners BDC Venture Capital INKEF Capital Domain Associates NewView Capital Sanofi Ventures MP Healthcare Venture Management Brandon Capital Partners AMR Action Fund EQT Life Sciences

Mission BioCapital Team

INVESTORS	INTRO STRENGTH	SWEET SPOT (RANGE)	INVESTMENT LOCATIONS	TOP INVESTMENT CATEGORIES
Cassidy Blundell Mission BioCapitalPrincipal	n/a	$1.5M ($100K - $5.0M)	Investors in Cambridge (MA)	Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists)
Zach Collins Mission BioCapitalPrincipal	n/a	$5.0M ($1M - $15.0M)	Investors in SF Bay Area (CA)	Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in Investors who invested in diverse founders (Other Lists) +1
Douglas Crawford Mission BioCapitalManaging Partner	n/a	$1.5M ($100K - $5.0M)	Investors in San Francisco (CA)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A) +4
Johannes Fruehauf Mission BioCapitalGeneral Partner	n/a	$1.5M ($100K - $5.0M)	Investors in Cambridge (MA)	Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Boston / New England (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +12
Jennifer Griffin Mission BioCapitalPartner	n/a	$1.5M ($100K - $5.0M)	Investors in Massachusetts	Investors in BioTech (Seed), Investors in BioTech (Series A)
Eric Linsley Mission BioCapitalGeneral Partner	n/a	$1.5M ($100K - $5.0M)	Investors in Durham (NC)	Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +9
Peter Parker Mission BioCapitalManaging Partner	n/a	$1.5M ($100K - $5.0M)	Investors in Cambridge (MA)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Boston / New England (Other Lists), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A) +8
Chaya Patel Mission BioCapitalAnalyst	n/a	$1.5M ($100K - $5.0M)	Investors in Cambridge (MA)	Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists)
Helen Siaw Mission BioCapitalAnalyst	n/a	$1.5M ($100K - $5.0M)	Investors in SF Bay Area (CA)	Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A)
Steve Tregay Mission BioCapitalManaging Partner	n/a	$1.5M ($100K - $5.0M)	Investors in Cambridge (MA)	Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Boston / New England (Other Lists), Investors in Health & Hospital Services (Seed) +5